Search
AI x Bio Summit: The Co-Founder and Head of Machine Learning at Dyno Therapeutics describes how his company is using AI to design better capsids
Sam Sinai talks about how capsids are being more precisely designed today, which is allowing drug developers to better target them to...
Jul 22
ASGCT 2025: Dyno Therapeutics' CEO Eric Kelsic discusses the latest in capsids for CNS, ophthalmology, and neuromuscular conditions
He talks about new capsids Dyno announced at this years' conference and the science behind getting them to specific places in the body....
May 15
Dyno Therapeutics is using AI to develop next generation AAV vectors for gene therapies
Co-Founder & CSO Adrian Veres and Head of Stewardship Tyson Bertmaring describe the shortcomings of wild type AAV that Dyno is trying to...
Oct 1, 2024
.png){kind=logo}
